Karim Saad Temsamani - 01 Dec 2023 Form 4 Insider Report for Cardlytics, Inc. (CDLX)

Role: Chief Executive Officer, Director
Signature: /s/ NicK Lynton, Attorney-in-Fact
Issuer symbol: CDLX
Transactions as of: 01 Dec 2023
Net transactions value: -$331,791
Form type: 4
Filing time: 05 Dec 2023, 19:53:13 UTC
Previous filing: 03 Oct 2023
Next filing: 03 Jan 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CDLX	Common Stock	Options Exercise	$0	+84,079	+39%	$0.000000	299,271	01 Dec 2023	Direct	F1
transaction	CDLX	Common Stock	Sale	$331,791	-40,413	-14%	$8.21	258,858	05 Dec 2023	Direct	F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CDLX	Restricted Stock Unit	Options Exercise	$0	-84,079	-8.3%	$0.000000	924,867	01 Dec 2023	Common Stock	84,079		Direct	F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents the underlying vested shares of common stock of the Issuer.
F2	Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for restricted stock units that vested on December 1, 2023.
F3	The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $8.02 to $8.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4	Each RSU represents a contingent right to receive one share of common stock of the Issuer, or at the election of the Issuer, its cash equivalent.
F5	25% of the RSUs vested on September 1, 2023 with the remaining 75% vesting in equal amounts over the subsequent three years quarterly thereafter, provided that the Reporting Person remains employed by the Issuer on such vesting date.